Welcome to Acucela
Acucela is leveraging promising science in visual cycle modulation to develop new methods for treating blinding eye diseases that affect tens of millions of people worldwide.
Innovative Approach
Acucela’s visual cycle modulators selectively target cells within the retina to protect visual acuity and have the potential to be used to treat several devastating eye diseases, including dry age-related macular degeneration (AMD).
Patient Resources
Acucela is working to make our novel drug candidates for treating blinding eye diseases available to patients as rapidly as possible. Find information regarding our clinical trials and areas of research here.